SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Optimer Pharmaceuticals, Inc. Release: CMS Grants New Technology Add-on Payment to DIFICID® for Treatment of Clostridium difficile-Associated Diarrhea